Global Thrombosis Research Seminars
Network to Network Series
The INVENT-VTE Network Global Thrombosis Research Seminar Series showcases inspiring and high-impact thrombosis research initiatives, collaborations, and advancements from INVENT network-member countries.
The series is designed to showcase network-related research and initiatives that highlight:
- Endorsed Research and its contributions to the field
- Collaborations that drive practice-changing VTT research
- Key developments within national networks that enhance clinical VTE research.
- The critical role of international collaboration and INVENT’s leadership in fostering global research efforts.
- Innovative research initiatives that inspire and strengthen thrombosis research networks worldwide.
2025 Seminar Series
The 2025 series will feature three seminars throughout the year, each showcasing an INVENT-endorsed study with a special focus on its methodology. Every session will include presentations by international experts from across the INVENT-VTE Network, followed by a 15-minute Q&A to foster discussion and engagement.
Part 1: RENOVE TRIAL - Methodology, Study Design, & its Effect on Interpreting Results (Non-inferiority Vs Superiority Trials)
📅 Date: Wednesday, April 9, 2025
⏰ Time: 8:00 ET | 12:00 UTC | 14:00 CET
💻 Location: Virtual Seminar via zoom
The INVENT-VTE Network invites you to the first session of the 2025 seminar series, where we’ll take a deep dive into the recently published RENOVE Trial—examining its methodology, study design, and impact on interpreting results (non-inferiority vs. superiority trials).
Featured Speakers:
- Francis Couturaud, MD, PhD – Brest University, France
- Émilie Presles – CHU Saint Etienne, France
The RENOVE Trial, an INVENT-endorsed study recently published in The Lancet, provides crucial insights into thrombosis treatment strategies. 📖 Read the full article here.
🎤 Live Q&A: Attendees will also have the opportunity to participate in a 15-minute Q&A session, with the option to submit questions in advance.
🔗 Register now to secure your spot! Can't make it? Registrants will have early access to the seminar recording.
Past Seminars
Adaptive Trial Design: Advantages and Drawbacks of Bayesian Approaches in Clinical Trials
Date / Time: Thursday, March 30, 2023
Objectives:
- To present the principles of Bayesian statistics applied to clinical trials;
- To illustrate the advantages of bayesian approach in order to increase the feasibility of adaptive designs;
- To report the discussion about possible drawbacks of Bayesian approach in comparison with frequentist approach;
- To discuss the potential impact of the bayesian approach on the future of evidence based medicine.
Presenter: Eric Vicaut, MD, PhD | AP-HP, Hôpital Lariboisière - Fernand-Widal, Université Paris Cité, Paris, France
The Future of Interventional Cohort Studies & Insights from the RIVA-SVT Study
Date / Time: May 19, 2022
Learning Objective: Showcasing the international "Treatment of Splanchnic Vein Thrombosis With Rivaroxaban" (RIVA-SVT) Study followed by focused presentation on the Future of Intentional Cohort Studies.
Presenters: Walter Ageno, M.D. University of Insubria, Italy; Nicoletta Riva, M.D. Ph.D. University of Malta, Malta
A Proposed Definition of Postpartum Hemorrhage (PPH) & Insights from the HIGHLOW Study
Date / Time: February 9, 2022
Objective: Showcasing the international HIGHLOW Study followed by a proposed definition of PPH
Presenters:
- Laurent Bertoletti, M.D. Ph.D. (INNoVTE - France)
- Bernard Tardy, M.D. Ph.D. (INNoVTE - France)
- Saskia Middeldorp, M.D. Ph.D. (Dutch Thrombosis Network - the Netherlands
Building Patient Engagement in Thrombosis Research
Date / Time: November 3, 2021
Objective: Showcasing two unique national efforts to improve and integrate patient engagement in clinical VTE / thrombosis research
Featuring:
- Dr. Fionnuala Ni Ainle | Ann Marie O’Neill ( INViTE / Thrombosis Ireland - Ireland)
- Dr. Lisa Duffett | Carol West (CanVECTOR - Canada)
Application Form
Subscribe